Sienna Biopharmaceuticals, Inc. (SNNA) financial statements (2021 and earlier)

Company profile

Business Address 30699 RUSSELL RANCH ROAD, SUITE 140
WESTLAKE VILLAGE, CA 91362
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4974
Cash and cash equivalents4974
Restricted cash and investments00
Other undisclosed current assets23
Total current assets:5077
Noncurrent Assets
Property, plant and equipment00
Intangible assets, net (including goodwill)1111
Goodwill1111
Other undisclosed noncurrent assets4648
Total noncurrent assets:5760
TOTAL ASSETS:107137
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities118
Accounts payable32
Accrued liabilities53
Employee-related liabilities33
Business combination, contingent consideration, liability14 
Other undisclosed current liabilities00
Total current liabilities:248
Noncurrent Liabilities
Long-term debt and lease obligation30 
Long-term debt, excluding current maturities30 
Liabilities, other than long-term debt2634
Deferred tax liabilities, net1111
Business combination, contingent consideration, liability1623
Other undisclosed noncurrent liabilities04
Total noncurrent liabilities:5637
Total liabilities:8146
Stockholders' equity
Stockholders' equity attributable to parent2791
Common stock 0
Additional paid in capital183172
Accumulated other comprehensive income35
Accumulated deficit(159)(86)
Total stockholders' equity:2791
TOTAL LIABILITIES AND EQUITY:107137

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
Operating expenses(76)(49)
Operating loss:(76)(49)
Nonoperating income (expense)3(2)
Loss from continuing operations before income taxes:(73)(51)
Income tax benefit 0
Net loss available to common stockholders, diluted:(73)(51)

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
Net loss:(73)(51)
Other comprehensive loss(2) 
Comprehensive loss:(76)(51)
Other undisclosed comprehensive income, net of tax, attributable to parent 6
Comprehensive loss, net of tax, attributable to parent:(76)(45)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: